EV71 virus like particle vaccine recombinant - Shanghai Zerun Biotechnology
Alternative Names: Recombinant Enterovirus 71 (EV71) vaccine; Recombinant EV71 VLP vaccineLatest Information Update: 28 Jul 2023
At a glance
- Originator Shanghai Zerun Biotechnology Co
- Class Enterovirus vaccines; Synthetic vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Enterovirus A infections
Most Recent Events
- 28 Jul 2023 No recent reports of development identified for preclinical development in Enterovirus A infections(Prevention) in China (IM)
- 30 Aug 2021 National Food and Drug Administration approves IND application for EV71 virus-like particle vaccine (Shanghai Zerun Biotechnology website, August 2021)
- 01 Jun 2019 Preclinical trials in Enterovirus A infections in China (IM) (Shanghai Zerun Biotechnology pipeline, prior to June 2019)